GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biofarm SA (BSE:BIO) » Definitions » Price-to-Funds-From-Operations

Biofarm (BSE:BIO) Price-to-Funds-From-Operations : (As of Apr. 11, 2025)


View and export this data going back to 1996. Start your Free Trial

What is Biofarm Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Biofarm Business Description

Industry
Traded in Other Exchanges
N/A
Address
99 Logofatul Tautu Street, Sector 3, Bucharest, ROU, 031212
Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.